Trade EVMN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Evommune, Inc. (EVMN) is trading at US$6.22, down 5.90% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$508.82M. Over the past 52 weeks, EVMN has traded between US$6.08 and US$33.20. On Syfe you can trade EVMN with $0 commission and add it to your watchlist.
| Previous close | US$6.61 |
|---|---|
| Market cap | US$508.82M |
| 52-week range | US$6.08 – US$33.20 |
| Volume | 2.11M |
| Exchange | US |
Evommune, Inc.
Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.
Year: 2025
Needham Initiates Evommune at Buy With $28 Price Target
Aug 26, 11:29 AM · MT Newswires
Evommune, Inc. (EVMN) stock is trading at US$6.22, -5.90% from the previous close of US$6.61.
The market cap for Evommune, Inc. (EVMN) stock is approximately US$508.82M.
The 52-week high for Evommune, Inc. (EVMN) stock is US$33.20.
The 52-week low for Evommune, Inc. (EVMN) stock is US$6.08.
Evommune, Inc. (EVMN) does not currently pay a dividend.
Stay on top of EVMN
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
